Showing results (2491-2500 of 2,542) with videos related to

Sort By:
Pageof 255
Cell Reports. Medicine|August 22, 2024
Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2Joseph A Bell, Elizabeth R Davies, Christopher J Brereton, et al.
Blood|July 29, 2026
Prime editing enables drug-controllable T-cell therapies with clinical immunosuppressionEsther Bandala-Sanchez, Emma V Petley, Kerry Ramsay, et al.
JCI Insight|October 5, 2016
Adjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondiiKamal El Bissati, Aziz A Chentoufi, Paulette A Krishack, et al.
Frontiers in Cellular and Infection Microbiology|October 23, 2018
CSGID Solves Structures and Identifies Phenotypes for Five Enzymes in Toxoplasma gondiiJoseph D Lykins, Ekaterina V Filippova, Andrei S Halavaty, et al.
Leukemia|September 15, 2018
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemiaDonia M Moujalled, Giovanna Pomilio, Corina Ghiurau, et al.
Neurosurgery|August 11, 2016
Defining Glioblastoma Resectability Through the Wisdom of the Crowd: A Proof-of-Principle StudyAdam M Sonabend, Brad E Zacharia, Michael B Cloney, et al.
Blood Advances|November 1, 2021
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignanciesConstantine S Tam, Meletios Dimopoulos, Ramon Garcia-Sanz, et al.
Blood Advances|June 23, 2020
Cotargeting BCL-2 and MCL-1 in high-risk B-ALLDonia M Moujalled, Diane T Hanna, Soroor Hediyeh-Zadeh, et al.
Plos Genetics|August 31, 2011
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffeeTaye H Hamza, Honglei Chen, Erin M Hill-Burns, et al.
Science (New York, N.Y.)|August 5, 2017
The biology of colorInnes C Cuthill, William L Allen, Kevin Arbuckle, et al.
Pageof 255